NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/22/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,505.42 mln
Float92.54 mln
Earnings Date07/30/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-1.58
Likely manipulated
1-Year Forecast
34.62
Transformational upside
Relative Strength
36
/ 100
Underperforming
Debt / Equity
0.60
Moderate leverage
ROE
-10.26
Negative
Business Description
Arcutis Biotherapeutics is a California-based company founded in 2016 that researches and brings to market new medicines for skin conditions. Its flagship product, ZORYVE, is available as both a cream and a foam to treat conditions such as plaque psoriasis, atopic dermatitis, and seborrheic dermatitis. The company is also working on an experimental treatment called ARQ-234, which targets the immune system to address skin disease in a novel way.
